EUVIMED · CrossrefZeitschrift
Nature Chemical Biology
ISSN 1552-4450 · Springer Science and Business Media LLC
Neueste Artikel
An engineered nanobody inhibitor for molecular-to-circuit control of opioid receptors
Yeast designed to specifically measure cancer proteases
Histone succinylation by NCOA1/2/3 drives mediator association and transcription
Designing de novo metalloproteases
A bittersweet victory
Death marks the spot
NuRDing out
FlAsH-ID enables live-cell photoproximity labeling with a short peptide tag
Temperature dependence of binding entropy drives evolution in LacI family proteins
Molecular echoes of a hot Earth
A chemical key to the brain
A conformation-sensitive product inhibitor of HDAC1/2 potentiates WNT signaling
A conserved urate oxidase helix-tiling assembly promotes metabolic robustness in peroxisomes
Structure of chlorophyll synthase in complex with the LHC-like protein HliD
Photoprotection in the making
Membrane flexibility matters
Bringing peroxisomes within reach
PerCap isolates native peroxisomes to reveal peroxisomal proteins and regulators
Pol II reshapes DNA damage
Tackling the Tankyrase twins
A selective TNKS2 inhibitor for tumor-restricted WNT suppression
Biosynthetic tailoring of polyene antifungals
Abasic CRISPR RNAs inherently harness fidelity of SpCas9 for genome editing
Designing chemigenetic DNA nanotrap for norepinephrine dynamic imaging in organelles
Rotation of the N-terminal helix triggers Gα activation
In vivo-compatible spatial multi-omics via hydrogen peroxide-independent APEX2 labeling
DHODH is the key target of the KDM4 inhibitor QC6352 in glioblastoma stem cells
Transcription remodeling and stalling by cisplatin-induced interstrand crosslinks
IDO1 regulating ROS rhythm reveals glycogenolysis/PPP as a cancer treatment target
Dual E3 ligase recruitment by monovalent degraders for tunable SMARCA 2/4 degradation
EUVIMED